Safety profile of end-stage heart failure patients implanted with left ventricular assist devices. Krakow two-year observational all-comers study on left ventricular assist device recipients.

1Department of Cardiac and Vascular Diseases, Institute of Cardiology, Jagiellonian University Medical College, John Paul II Hospital, Krakow, Poland 2Department of Cardiovascular Surgery and Transplantology, Institute of Cardiology, Jagiellonian University Medical College, John Paul II Hospital, Krakow, Poland 3Department of Coronary Disease and Heart Failure, Institute of Cardiology, Jagiellonian University Medical College, John Paul II Hospital, Krakow, Poland 4Department of Anaesthesiology and Intensive Therapy, Jagiellonian University Medical College, John Paul II Hospital, Krakow, Poland

[1]  M. Senni,et al.  Prediction of right ventricular failure after ventricular assist device implant: systematic review and meta‐analysis of observational studies , 2017, European journal of heart failure.

[2]  Gregory A. Ewald,et al.  A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure , 2017, The New England journal of medicine.

[3]  M. Kuśmierczyk,et al.  First implantation of a HeartMate 3 left ventricular assist device in Poland. , 2016, Kardiologia polska.

[4]  Volkmar Falk,et al.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.

[5]  Robert L Kormos,et al.  Seventh INTERMACS annual report: 15,000 patients and counting. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[6]  Biykem Bozkurt,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.

[7]  Yoshifumi Naka,et al.  Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). , 2011, Journal of the American College of Cardiology.

[8]  M C Oz,et al.  Long-term use of a left ventricular assist device for end-stage heart failure. , 2001, The New England journal of medicine.